Sd Biosensor Healthcare Profile
Key Indicators
- Authorised Capital ₹ 200.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 178.47 Cr
as on 07-07-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 66.25 Cr
as on 07-07-2024
- Revenue -71.99%
(FY 2023)
- Profit -418.28%
(FY 2023)
- Ebitda -215.78%
(FY 2023)
- Net Worth 40.95%
(FY 2023)
- Total Assets 7.55%
(FY 2023)
About Sd Biosensor Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 200.00 Cr and a paid-up capital of Rs 178.47 Cr.
The company has closed loans amounting to ₹66.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sd Biosensor Healthcare Private Limited India are Atul Singh as COMPANY SECRETARY and Manish Varshney as Cfo. Sung Kim, Young Cho, and Kwang Lee serve as directors at the Company.
- CIN/LLPIN
U33110HR2012PTC047034
- Company No.
047034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2012
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sd Biosensor Healthcare Private Limited offer?
Sd Biosensor Healthcare Private Limited offers a wide range of products and services, including Rapid Test Kit, Diagnostic Test Kit, Glucometer, Dr Morepen Glucometer, Medical Laboratory Instruments, IVDs & Analyzers, Blood Bank Equipments, Hematology Analyzers, Hemoglobin Meter, Blood Pressure Machine.
Who are the key members and board of directors at Sd Biosensor Healthcare?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Atul Singh | Company Secretary | 15-Feb-2020 | Current |
Manish Varshney | CFO | 01-Apr-2022 | Current |
Financial Performance of Sd Biosensor Healthcare.
Sd Biosensor Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 71.99% decrease. The company also saw a substantial fall in profitability, with a 418.28% decrease in profit. The company's net worth Soared by an impressive increase of 40.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sd Biosensor Healthcare?
In 2023, Sd Biosensor Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 May 2022 | ₹14.75 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 06 May 2022 | ₹38.00 Cr | Satisfied |
Industrial Bank Of Korea Creation Date: 27 Jun 2018 | ₹13.50 Cr | Satisfied |
How Many Employees Work at Sd Biosensor Healthcare?
Sd Biosensor Healthcare has a workforce of 246 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sd Biosensor Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sd Biosensor Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.